NPPA fixes prices of 58 drug formulations - (The Economic Times via NewsPoints Desk)

  • India's National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 56 formulations and also capped the ceiling prices of two formulations, reported The Economic Times.

  • The formulations include treatments for various diseases, including cardiac conditions, anxiety disorders, hepatitis C and diabetes.

  • Specifically, some of the drugs include sofosbuvir and ledipasvir used for treatment of hepatitis C.

  • The NPPA has also fixed the retail price of teneligliptin metformin used for the treatment of diabetes, and capped the ceiling prices of digoxin and furosemide oral liquids.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles